The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Primary pulmonary lymphoma
Open accessAbstract
Three distinct entities are now covered by the definition of primary pulmonary clonal lymphoid proliferation. The aim of this review is to describe the pathophysiological, diagnostic, prognostic and therapeutic aspects of these three entities. Low-grade pulmonary B-cell lymphoma is the most frequent form of primary pulmonary clonal lymphoid proliferation. It arises from mucosa-associated lymphoid tissue. It is usually indolent and appears in the form of a chronic alveolar opacity. The prognosis is excellent, but treatment is controversial (simple monitoring, surgery or single-agent chemotherapy). High-grade pulmonary B-cell lymphoma is far rarer and usually occurs in individuals with an underlying disorder (e.g.immunodeficiency). The prognosis is poor and therapeutic options depend on the underlying disorder. The inclusion of lymphomatoid granulomatosis in the definition of primary pulmonary lymphomas is controversial. The clonal nature of the proliferation is very rarely demonstrated and extrapulmonary involvement is frequent (upper airways, skin, kidneys, central nervous system,etc.). The prognosis is extremely variable, with some authors reporting complete remission with steroids and cyclophosphamide and others reporting failure of combination chemotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Harris, N., Jaffe, E., Stein, H., Banks, P., Chan, J., Cleary, M., Delsol, G., De Wolf- Peeters, C., Falini, B., & Gatter, K. (1994) · Blood · doi:10.1182/blood.v84.5.1361.1361 · Cited by 6,327
Starzl, T. E., Porter, K. A., Iwatsuki, S., Rosenthal, J. T., Shaw, B. W., Atchison, R. W., Nalesnik, M., Ho, M., Griffith, B. P., Hakala, T. R., et al. (1984) · The Lancet · doi:10.1016/s0140-6736(84)90994-2 · Cited by 1,234
FAUCI, A. S., HARLEY, J. B., ROBERTS, W. C., FERRANS, V. J., GRALNICK, H. R., & BJORNSON, B. H. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-97-1-78 · Cited by 823
Nalesnik, M. A., Jaffe, R., Starzl, T. E., et al. (1988) · PubMed · Cited by 700
Thieblemont, C., Berger, F., Dumontet, C., Moullet, I., Bouafia, F., Felman, P., Salles, G., & Coiffier, B. (2000) · Blood · doi:10.1182/blood.v95.3.802.003k19_802_806 · Cited by 518
Cordier, J.-F., Chailleux, E., Lauque, D., Reynaud-Gaubert, M., Dietemann-Molard, A., Dalphin, J. C., Blanc-Jouvan, F., & Loire, R. (1993) · Chest · doi:10.1378/chest.103.1.201 · Cited by 353
Harris, N. L., Jaffe, E. S., Diebold, J., Flandrin, G., Muller-Hermelink, H. K., & Vardiman, J. (2000) · Annals of Oncology · doi:10.1093/annonc/11.suppl_1.s3 · Cited by 329
Remstein, E. D., James, C. D., & Kurtin, P. J. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64988-7 · Cited by 210
Pathologic and Clinical Spectrum of Post-Thymic T-Cell Malignancies
Jaffe, E. S. (1984) · Cancer Investigation · doi:10.3109/07357908409040316 · Cited by 207
Morgner, A., Miehlke, S., Fischbach, W., Schmitt, W., Müller-Hermelink, H., Greiner, A., Thiede, C., Schetelig, J., Neubauer, A., Stolte, M., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.7.2041 · Cited by 190
Metadata
- Authors
- Cadranel, J., Wislez, M., & Antoine, M.
- Venue
- European Respiratory Journal
- Publisher
- European Respiratory Society (ERS)
- Published
- 2002-09
- Volume
- 20
- Issue
- 3
- Pages
- 750-762
- ISSN
- 0903-1936 (ISSN-L)
- 1399-3003
- OpenAlex
- W2142109384
- Cited by
- 418
- References
- 16
- FWCI
- 4.97
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Primary pulmonary lymphoma. https://app.cochat.ai/papers/10.1183/09031936.02.00404102
- The paper
- Cadranel, J., Wislez, M., & Antoine, M. (2002). Primary pulmonary lymphoma. European Respiratory Journal. https://doi.org/10.1183/09031936.02.00404102
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.